BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 151287)

  • 1. Dopaminergic control of adenohypophyseal growth after oestrogens: negative results with L-DOPA, RO-4-4602, alpha-methyl-DOPA, apomorphine, haloperidol, pyridoxine and cyproheptadine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1978; 27(4):308-12. PubMed ID: 151287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic control of adenohypophyseal growth.
    Schreiber V
    Vopr Biokhim Mozga; 1978; 13():221-7. PubMed ID: 756643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hexose monophosphate shunt inhibitors on adenohypophyseal and ceruloplasmin reactions to oestrogen.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1978; 27(4):301-7. PubMed ID: 151286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic modulation of the adenohypophyseal reaction to oestradiol: interaction of perphenazine with the thyroid hormones.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1980; 29(2):173-9. PubMed ID: 6446099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic antagonists potentiate the adenohypophyseal growth reaction to oestrogen: thioridazine is less effective than perphenazine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1987; 36(1):9-13. PubMed ID: 2884683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of L-dopa alone and with benserazide on the spontaneous activity of striatal neurones in normal and 6-hydroxydopamine-lesioned rats.
    Chang WY; Webster RA
    Br J Pharmacol; 1997 May; 121(2):331-7. PubMed ID: 9154345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between gnawing compulsion and central dopaminergic mechanism in guinea pigs (author's transl)].
    Uemura H
    Nihon Yakurigaku Zasshi; 1979 Jan; 75(1):61-72. PubMed ID: 571393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial inhibition of oestrogen-induced adenohypophyseal growth by silver nitrate.
    Pribyl T; Jahodová J; Schreiber V
    Horm Res; 1980; 12(5):296-303. PubMed ID: 7399401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apomorphine-induced myocardial protection is due to antioxidant and not adrenergic/dopaminergic effects.
    Khaliulin I; Schneider A; Houminer E; Borman JB; Schwalb H
    Free Radic Biol Med; 2006 May; 40(10):1713-20. PubMed ID: 16678010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of catecholaminergic substances on the circular reaction caused by stimulation of the caudate nucleus].
    Dutov AA
    Farmakol Toksikol; 1976; 39(5):537-40. PubMed ID: 1028579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin on the central action of dopamine.
    Braszko J; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactions of hypothalamic ascorbic acid, serum ceruloplasmin and the adenohypophysis to oestradiol: inhibition by L-thyroxine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1980; 29(1):11-20. PubMed ID: 6444734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.
    Horowski R; Gräf HJ
    Neuroendocrinology; 1976; 22(3):273-86. PubMed ID: 1028957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the oestradiol-induced increase in adenohypophyseal weight and in hypothalamic and serum polyphenol oxidase activity by dopaminergic agonists.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1983; 32(2):117-20. PubMed ID: 6408657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On certain effects of dopaminergic agents in pentylenetetrazol convulsions.
    Lazarova MB; Roussinov KS
    Acta Physiol Pharmacol Bulg; 1978; 4(3):50-5. PubMed ID: 751452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
    Silva MA; Mattern C; Häcker R; Tomaz C; Huston JP; Schwarting RK
    Synapse; 1997 Dec; 27(4):294-302. PubMed ID: 9372552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with levodopa and/or selegiline does not affect behavioral recovery induced by fetal ventral mesencephalic grafts in unilaterally 6-hydroxydopamine-lesioned rats.
    Adams CE; Hoffman AF; Hudson JL; Hoffer BJ; Boyson SJ
    Exp Neurol; 1994 Dec; 130(2):261-8. PubMed ID: 7867755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by an ergoline derivative (dopaminergic agonist) of oestradiol-induced adenohypophyseal growth and of the decrease in the hypothalamic ascorbic acid (HAA) concentration in rats.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1982; 31(2):97-100. PubMed ID: 6212960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoclopramide potentiates the hypophyseal reactions to oestradiol.
    Schreiber V; Dusková J; Pribyl T; Svobodová V; Jahodová J
    Physiol Bohemoslov; 1984; 33(5):385-9. PubMed ID: 6505072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.